UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 655

Sortiert nach

EULAR evidence-based recommendations for the management of fibromyalgia syndrome

Annals of the rheumatic diseases, 2008-04, Vol.67 (4), p.536-541

2008

Volltextzugriff (PDF)

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Annals of the rheumatic diseases, 2007-12, Vol.66 (12), p.1560-1567

2007

Volltextzugriff (PDF)

Fatigue in rheumatoid arthritis reflects pain, not disease activity

Rheumatology (Oxford, England), 2006-07, Vol.45 (7), p.885-889

2006

Volltextzugriff (PDF)

A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis

Annals of the rheumatic diseases, 2008-06, Vol.67 (6), p.855-859

2008

Volltextzugriff (PDF)

Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis

Annals of the rheumatic diseases, 2008-05, Vol.67 (5), p.656-663

2008

Volltextzugriff (PDF)

A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal

Rheumatology (Oxford, England), 2005-11, Vol.44 (11), p.1414-1421

2005

Volltextzugriff (PDF)

Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Annals of the rheumatic diseases, 2010-06, Vol.69 (6), p.1015-1021

2010

Volltextzugriff (PDF)

Efficacy of a novel PEGylated humanized anti‐TNF fragment (CDP870) in patients with rheumatoid arthritis: a phase II double‐blinded, randomized, dose‐escalating trial

Rheumatology (Oxford, England), 2002-10, Vol.41 (10), p.1133-1137

2002

Volltextzugriff (PDF)

Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials

Annals of the rheumatic diseases, 2007-10, Vol.66 (10), p.1296-1304

2007

Volltextzugriff (PDF)

Treatment of dermatomyositis and polymyositis

Rheumatology (Oxford, England), 2002-01, Vol.41 (1), p.7-13

2002

Volltextzugriff (PDF)

The consequences of rheumatoid arthritis: quality of life measures in the individual patient

Clinical and experimental rheumatology, 2005-09, Vol.23 (5 Suppl 39), p.S43

2005

Volltextzugriff (PDF)

Fibromyalgia: management strategies for primary care providers

International journal of clinical practice (Esher), 2016-02, Vol.70 (2), p.99-112

2016

Volltextzugriff (PDF)

A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs

Annals of the rheumatic diseases, 2005-09, Vol.64 (9), p.1288-1293

2005

Volltextzugriff (PDF)

Dual enteric and respiratory tropisms of winter dysentery bovine coronavirus in calves

Archives of virology, 2007-10, Vol.152 (10), p.1885-1900

2007

Volltextzugriff (PDF)

Joint inflammation and cytokine inhibition in rheumatoid arthritis

Clinical and experimental medicine, 2006-03, Vol.6 (1), p.13-19

2006

Volltextzugriff (PDF)

Limited correlation between the Health Assessment Questionnaire (HAQ) and EuroQol in rheumatoid arthritis: questionable validity of deriving quality adjusted life years from HAQ

Annals of the rheumatic diseases, 2007-11, Vol.66 (11), p.1534-1537

2007

Volltextzugriff (PDF)

A randomised, double-blind, placebo-controlled trial of a recombinant version of human α-fetoprotein (MM-093) in patients with active rheumatoid arthritis

Annals of the rheumatic diseases, 2007-05, Vol.66 (5), p.687-689

2007

Volltextzugriff (PDF)

Safety of medium- to long-term glucocorticoid therapy in rheumatoid arthritis: a meta-analysis

Rheumatology (Oxford, England), 2009-07, Vol.48 (7), p.807-811

2009

Volltextzugriff (PDF)

Defective CD8+CD28− regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy

Clinical and experimental immunology, 2013-10, Vol.174 (1), p.18-26

2013

Volltextzugriff (PDF)

Juvenile dermatomyositis: new clinical trial evidence to underpin therapeutic shared decision making

British journal of dermatology (1951), 2016-10, Vol.175 (4), p.665-666

2016

Volltextzugriff (PDF)

Enhanced and persistent levels of interleukin (IL)‐17+CD4+ T cells and serum IL‐17 in patients with early inflammatory arthritis

Clinical and experimental immunology, 2013-11, Vol.174 (2), p.292-301

2013

Volltextzugriff (PDF)

Are clinical trials in rheumatoid arthritis generalizable to routine practice? A re-evaluation of trial entry criteria

Rheumatology (Oxford, England), 2005-05, Vol.44 (5), p.629-632

2005

Volltextzugriff (PDF)

Selective modulation of T-cell co-stimulation: a novel mode of action for the treatment of rheumatoid arthritis

Clinical and experimental rheumatology, 2009-05, Vol.27 (3), p.510

Choy, E H

2009

Volltextzugriff (PDF)

Repeat‐cycle study of high‐dose intravenous 4162W94 anti‐CD4 humanized monoclonal antibody in rheumatoid arthritis. A randomized placebo‐controlled trial

Rheumatology (Oxford, England), 2002-10, Vol.41 (10), p.1142-1148

2002

Volltextzugriff (PDF)

Two is better than one? Combination therapy in rheumatoid arthritis

Rheumatology (Oxford, England), 2004-10, Vol.43 (10), p.1205-1207

Choy, E H

2004

Volltextzugriff (PDF)

1 – 25 von 655

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(569)
Mit Volltextzugriff
(581)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

EULAR evidence-based recommendations for the management of fibromyalgia syndrome

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Fatigue in rheumatoid arthritis reflects pain, not disease activity

A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis

Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis

A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal

Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Efficacy of a novel PEGylated humanized anti‐TNF fragment (CDP870) in patients with rheumatoid arthritis: a phase II double‐blinded, randomized, dose‐escalating trial

Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials

Treatment of dermatomyositis and polymyositis

The consequences of rheumatoid arthritis: quality of life measures in the individual patient

Fibromyalgia: management strategies for primary care providers

A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs

Dual enteric and respiratory tropisms of winter dysentery bovine coronavirus in calves

Joint inflammation and cytokine inhibition in rheumatoid arthritis

Limited correlation between the Health Assessment Questionnaire (HAQ) and EuroQol in rheumatoid arthritis: questionable validity of deriving quality adjusted life years from HAQ

A randomised, double-blind, placebo-controlled trial of a recombinant version of human α-fetoprotein (MM-093) in patients with active rheumatoid arthritis

Safety of medium- to long-term glucocorticoid therapy in rheumatoid arthritis: a meta-analysis

Defective CD8+CD28− regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy

Juvenile dermatomyositis: new clinical trial evidence to underpin therapeutic shared decision making

Enhanced and persistent levels of interleukin (IL)‐17+CD4+ T cells and serum IL‐17 in patients with early inflammatory arthritis

Are clinical trials in rheumatoid arthritis generalizable to routine practice? A re-evaluation of trial entry criteria

Selective modulation of T-cell co-stimulation: a novel mode of action for the treatment of rheumatoid arthritis

Repeat‐cycle study of high‐dose intravenous 4162W94 anti‐CD4 humanized monoclonal antibody in rheumatoid arthritis. A randomized placebo‐controlled trial

Two is better than one? Combination therapy in rheumatoid arthritis

Suchergebnisse filtern